Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production.

Simon MF, Rey A, Castan-Laurel I, Grés S, Sibrac D, Valet P, Saulnier-Blache JS.

J Biol Chem. 2002 Jun 28;277(26):23131-6. Epub 2002 Apr 15.

2.

Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.

Ferry G, Tellier E, Try A, Grés S, Naime I, Simon MF, Rodriguez M, Boucher J, Tack I, Gesta S, Chomarat P, Dieu M, Raes M, Galizzi JP, Valet P, Boutin JA, Saulnier-Blache JS.

J Biol Chem. 2003 May 16;278(20):18162-9. Epub 2003 Mar 17.

3.

Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3F442A preadipocyte proliferation and spreading.

Pages C, Daviaud D, An S, Krief S, Lafontan M, Valet P, Saulnier-Blache JS.

J Biol Chem. 2001 Apr 13;276(15):11599-605. Epub 2001 Jan 4.

4.

Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.

Simon MF, Daviaud D, Pradère JP, Grès S, Guigné C, Wabitsch M, Chun J, Valet P, Saulnier-Blache JS.

J Biol Chem. 2005 Apr 15;280(15):14656-62. Epub 2005 Feb 14.

5.

Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis.

Gesta S, Simon MF, Rey A, Sibrac D, Girard A, Lafontan M, Valet P, Saulnier-Blache JS.

J Lipid Res. 2002 Jun;43(6):904-10.

6.

Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth.

Valet P, Pagès C, Jeanneton O, Daviaud D, Barbe P, Record M, Saulnier-Blache JS, Lafontan M.

J Clin Invest. 1998 Apr 1;101(7):1431-8.

7.

LPA as a paracrine mediator of adipocyte growth and function.

Pagès G, Girard A, Jeanneton O, Barbe P, Wolf C, Lafontan M, Valet P, Saulnier-Blache JS.

Ann N Y Acad Sci. 2000 Apr;905:159-64. Review.

PMID:
10818451
8.

Molecular cloning and expression of pulmonary lipid phosphate phosphohydrolases.

Nanjundan M, Possmayer F.

Am J Physiol Lung Cell Mol Physiol. 2001 Dec;281(6):L1484-93.

9.

Effects of lysophosphatidic acid on the in vitro proliferation and differentiation of a novel porcine preadipocyte cell line.

Nobusue H, Kondo D, Yamamoto M, Kano K.

Comp Biochem Physiol B Biochem Mol Biol. 2010 Dec;157(4):401-7. doi: 10.1016/j.cbpb.2010.08.010. Epub 2010 Sep 15.

PMID:
20826223
10.

Lysophosphatidic acid protection against apoptosis in the human pre-B-cell line Nalm-6.

Satoh Y, Ohkawa R, Nakamura K, Higashi K, Kaneko M, Yokota H, Aoki J, Arai H, Yuasa Y, Yatomi Y.

Eur J Haematol. 2007 Jun;78(6):510-7. Epub 2007 Apr 5.

PMID:
17419739
11.

Tissue expression of porcine FoxO1 and its negative regulation during primary preadipocyte differentiation.

Pang WJ, Yu TY, Bai L, Yang YJ, Yang GS.

Mol Biol Rep. 2009 Jan;36(1):165-76. doi: 10.1007/s11033-007-9163-6. Epub 2008 Feb 22.

PMID:
18293098
12.

Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.

Tanyi JL, Hasegawa Y, Lapushin R, Morris AJ, Wolf JK, Berchuck A, Lu K, Smith DI, Kalli K, Hartmann LC, McCune K, Fishman D, Broaddus R, Cheng KW, Atkinson EN, Yamal JM, Bast RC, Felix EA, Newman RA, Mills GB.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3534-45.

13.

[Lysophosphatidic acid as a potential target for treatment and molecular diagnosis of epithelial ovarian cancers].

Tanyi J, Rigó J Jr.

Orv Hetil. 2009 Jun 14;150(24):1109-18. Review. Hungarian.

PMID:
19739275
14.

Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy.

Ito A, Suganami T, Miyamoto Y, Yoshimasa Y, Takeya M, Kamei Y, Ogawa Y.

J Biol Chem. 2007 Aug 31;282(35):25445-52. Epub 2007 Jul 3.

15.

Regulation of endogenous SH2 domain-containing inositol 5-phosphatase (SHIP2) in 3T3-L1 and human preadipocytes.

Gagnon A, Artemenko Y, Crapper T, Sorisky A.

J Cell Physiol. 2003 Nov;197(2):243-50.

PMID:
14502564
16.

Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability.

Johnson KR, Johnson KY, Becker KP, Bielawski J, Mao C, Obeid LM.

J Biol Chem. 2003 Sep 5;278(36):34541-7. Epub 2003 Jun 18.

17.

Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation.

Bouloumié A, Sengenès C, Portolan G, Galitzky J, Lafontan M.

Diabetes. 2001 Sep;50(9):2080-6.

18.

The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.

Tanyi JL, Morris AJ, Wolf JK, Fang X, Hasegawa Y, Lapushin R, Auersperg N, Sigal YJ, Newman RA, Felix EA, Atkinson EN, Mills GB.

Cancer Res. 2003 Mar 1;63(5):1073-82.

19.

Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.

Artemenko Y, Gagnon A, Sorisky A.

J Cell Physiol. 2009 Jan;218(1):228-36. doi: 10.1002/jcp.21595.

PMID:
18814181
Items per page

Supplemental Content

Write to the Help Desk